Table 1.
Baseline characteristic of the participants with available fecal samples in the study according to the sex
| CHD patients | Non-CVD subjects | |||||
|---|---|---|---|---|---|---|
| Men | Women | P-value | Men | Women | P-value | |
| N (men/women) | 567 | 112 | n.a | 242 | 87 | n.a |
| Age (years) | 59.1 ± 0.4 | 62.8 ± 0.8 | < 0.001 | 59.2 ± 0.6 | 59.6 ± 0.9 | 0.711 |
| BMI (kg/m2) | 31.1 ± 0.2 | 31.2 ± 0.5 | 0.821 | 29.5 ± 0.3 | 29.0 ± 0.6 | 0.393 |
| WC (cm) | 106.1 ± 0.5 | 99.0 ± 1.2 | < 0.001 | 101.9 ± 0.7 | 93.6 ± 1.7 | < 0.001 |
| HDL-c (mg/dL) | 41.2 ± 0.4 | 47.5 ± 1.2 | < 0.001 | 43.7 ± 0.6 | 54.7 ± 1.3 | < 0.001 |
| LDL-c (mg/dL) | 88.2 ± 1.1 | 91.7 ± 2.8 | 0.190 | 132.8 ± 2.0 | 130.9 ± 2.9 | 0.612 |
| TAG (mg/dL) | 136.5 ± 2.9 | 136.0 ± 7.3 | 0.953 | 122.1 ± 3.9 | 97.4 ± 4.6 | 0.001 |
| Fasting glucose (mg/dL) | 112.9 ± 1.6 | 115.8 ± 4.9 | 0.482 | 104.9 ± 1.4 | 93.8 ± 1.5 | < 0.001 |
| Fasting insulin (mU/l) | 10.5 ± 0.4 | 10.8 ± 1.2 | 0.764 | 8.8 ± 0.4 | 6.7 ± 0.5 | 0.008 |
| HbA1c (%) | 6.63 ± 0.05 | 6.74 ± 0.13 | 0.409 | 5.75 ± 0.20 | 5.47 ± 0.07 | 0.408 |
| Systolic BP (mmHg) | 137.6 ± 0.8 | 141.7 ± 1.9 | 0.046 | 142.5 ± 1.2 | 136.9 ± 2.3 | 0.021 |
| Diastolic BP (mmHg) | 77.5 ± 0.5 | 74.2 ± 0.9 | 0.004 | 84.6 ± 0.7 | 78.5 ± 1.2 | < 0.001 |
Values correspond to the mean ± SEM
BMI body mass index, WC waist circumference, HDL-c high density lipoprotein-cholesterol, LDL-c low density lipoprotein-cholesterol, TAG triacylglycerides, BP blood pressure
The statistical differences between groups were evaluated by one-way ANOVA